Ernesto Roldan-Valadez

Dr. Ernesto Roldan-Valadez

Division of Research, Instituto Nacional de Rehabilitación, Mexico City, Ciudad de México, Mexico
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2018 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Closed access
PDF file
Ernesto Roldan-ValadezErnesto Roldan-Valadez
Ernesto Roldan-Valadez
SSShirley Yoselin Salazar-Ruiz
Shirley Yoselin Salazar-Ruiz
RIRafael Ibarra-Contreras
Rafael Ibarra-Contreras
CRCamilo Rios
Camilo Rios

1 May 2020 in Clinical Nutrition
Verified
Journal Article
Closed access
OBOmar Yaxmehen Bello-Chavolla
Omar Yaxmehen Bello-Chavolla
NANeftali Eduardo Antonio-Villa
Neftali Eduardo Antonio-Villa
AVArsenio Vargas-Vázquez
Arsenio Vargas-Vázquez
TVTannia Leticia Viveros-Ruiz
Tannia Leticia Viveros-Ruiz
PAPaloma Almeda-Valdes
Paloma Almeda-Valdes
CACarlos A. Aguilar-Salinas
Carlos A. Aguilar-Salinas

1 July 2008 in Annals of Hepatology
Verified
Journal Article
Open access
Ernesto Roldan-ValadezErnesto Roldan-Valadez
Ernesto Roldan-Valadez
RFRafael Favila
Rafael Favila
MMManuel Martínez-López
Manuel Martínez-López
MUMisael Uribe
Misael Uribe
NMNahum Méndez-Sánchez
Nahum Méndez-Sánchez
Nonalcoholic fatty liver disease (NAFLD), an emerging clinical entity with worldwide recognition, is today the most common cause of abnormal liver function tests among adults in the United States. In Mexico City, its prevalence has been reported by our group to be around 14%, but its incidence is higher in the hispanic population in the United States (hispanic population 45%, white population 33%, black population 24%). The main issues in the diagnosis, follow-up, and management of NAFLD are our limited understanding of its pathophysiology and the difficulties involved in developing a noninvasive diagnostic method. Several imaging techniques can detect fatty infiltration of the liver, each with its own advantages and disadvantages. Ultrasound is still in the first option for diagnosis, but its accuracy depends on the operator and the patient's features. Computed tomography can detect hepatic fat content, but only at a threshold of 30%, and it involves ionizing radiation. Magnetic resonance (MR) spectroscopy is probably the most accurate and fastest method of detecting fat, but it is expensive and the necessary software is still not easily available in most MRI units. MR elastography, a new technique to detect liver stiffness, has not been demonstrated to detect NAFLD, and is still undergoing research in patients with hepatitis and cirrhosis. In conclusion, all these imaging tools are limited in their ability to detect coexisting inflammation and fibrosis. In this review, we discuss the radiological techniques currently used to detect hepatic fat content.

21 July 2022 in Current Problems in Cardiology
Verified
Journal Article
Closed access
CGCesar-Alejandro Gil-Garcia
Cesar-Alejandro Gil-Garcia
EFEduardo Flores-Alvarez
Eduardo Flores-Alvarez
RCRicardo Cebrian-Garcia
Ricardo Cebrian-Garcia
AMAbril-Carolina Mendoza-Lopez
Abril-Carolina Mendoza-Lopez
LGLeslie-Marisol Gonzalez-Hermosillo
Leslie-Marisol Gonzalez-Hermosillo
Ernesto Roldan-ValadezErnesto Roldan-Valadez
Ernesto Roldan-Valadez

1 October 2010 in Journal of Hepatology
Verified
Journal Article
Closed access
Ernesto Roldan-ValadezErnesto Roldan-Valadez
Ernesto Roldan-Valadez
RFRafael Favila
Rafael Favila
MMManuel Martínez-López
Manuel Martínez-López
MUMisael Uribe
Misael Uribe
CRCamilo Ríos
Camilo Ríos
NMNahum Méndez-Sánchez
Nahum Méndez-Sánchez

6 February 2019 in La radiologia medica
Verified
Journal Article
Closed access
PDF file
MVMoises Villaseñor-Almaraz
Moises Villaseñor-Almaraz
JIJuan Islas-Serrano
Juan Islas-Serrano
CMChiharu Murata
Chiharu Murata
Ernesto Roldan-ValadezErnesto Roldan-Valadez
Ernesto Roldan-Valadez